Magenta Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Magenta Therapeutics Inc
TickerDNTH
CIK #0001690585
CUSIP252828108
SectorLife Sciences - Pharmaceutical Preparations
Address50 Hampshire Street, Cambridge, MA 02139
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Magenta Therapeutics Inc 2018-04-09 52.3 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001690585] 10-K
[0001690585] 10-Q
[0001690585] 3
[0001690585] 4
[0001690585] 5
[0001690585] 8-K
[0001690585] D
[0001690585] SC 13D
[0001690585] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Sirenia Capital Management LP Dianthus Therapeutics Inc /DE/ [2026-05-15] 0.0
BlackRock Inc Dianthus Therapeutics Inc /DE/ [2026-04-27] 0.0
Wellington Management Group LLP Dianthus Therapeutics Inc /DE/ [2025-11-12] 0.0
Vestal Point Capital LP Dianthus Therapeutics Inc /DE/ [2025-05-15] 0.0
Point72 Asset Management LP Dianthus Therapeutics Inc /DE/ [2025-04-17] 0.0
Deep Track Capital LP Dianthus Therapeutics Inc /DE/ [2025-03-24] 0.0
TCG Crossover GP II LLC Dianthus Therapeutics Inc /DE/ [2024-11-22] 81945.1
BlackRock Inc Dianthus Therapeutics Inc /DE/ [2024-11-08] 5.6
BlackRock Inc Dianthus Therapeutics Inc /DE/ [2024-10-24] 5.6
Octagon Capital Advisors LP Dianthus Therapeutics Inc /DE/ [2024-10-11] 6.0
RA Capital Management LP Dianthus Therapeutics Inc /DE/ [2024-02-02] 9.99
BCLS Fund III Investments LP Dianthus Therapeutics Inc /DE/ [2024-02-02] 81949.99
Avidity Partners Management LP Dianthus Therapeutics Inc /DE/ [2024-01-31] 0.9
FMR LLC Dianthus Therapeutics Inc /DE/ [2023-11-13] 0.0
Viridian LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 8194.0
5AM Partners VII LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 7.1
Venrock Healthcare Capital Partners III LP Dianthus Therapeutics Inc /DE/ [2023-09-21] 6.3
Fairmount Funds Management LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 819412.7
Citadel Advisors LLC Magenta Therapeutics Inc [2023-05-15] 6.5
Tang Capital Partners LP Magenta Therapeutics Inc [2023-02-13] 9.7
RA Capital Management LP Magenta Therapeutics Inc [2022-09-26] 6.09
Aquilo Capital Management LLC Magenta Therapeutics Inc [2022-02-14] 5.4
Deep Track Capital LP Magenta Therapeutics Inc [2021-05-14] 7.14
Atlas Venture Fund X LP Magenta Therapeutics Inc [2020-07-14] 8.7
Gilder Gagnon Howe & Co LLC Magenta Therapeutics Inc [2020-02-14] 10.52
Gilder Gagnon Howe & Co LLC Magenta Therapeutics Inc [2019-06-10] 10.6
Eventide Asset Management LLC Magenta Therapeutics Inc [2019-02-13] 8.0
Atlas Venture Fund X LP Magenta Therapeutics Inc [2019-02-13] 14.6
Third Rock Ventures GP IV LP Magenta Therapeutics Inc [2019-02-13] 24.2
GV 2016 LP Magenta Therapeutics Inc [2019-02-12] 10.07
Casdin Capital LLC Magenta Therapeutics Inc [2018-07-02] 5.9
Form 3/4/5 Filer 2011 - 2026
Veness Adam M
Dianthus Therapeutics Inc /DE/
Randhawa Simrat
Romano Steven J
Read Simon
Lawton Alison Frances
Kango Sujay
McGeorge Anne
Violin Jonathan
Soteropoulos Paula
Savitz Ryan
Garcia Marino
Carr Edward
Kiselak Tomas
Fairmount Funds Management LLC
Moulder Leon O Jr
Harwin Peter Evan
Avidity Partners Management LP
Gregory Michael David
Meng Lei
Witzke David Roy
Avidity Partners Management GP LLC
Third Rock Ventures GP IV LP
Third Rock Ventures IV LP
TRV GP IV LLC
Stants Kristen
Mahoney Stephen F
Beetham Thomas W
Deardorf Caren
Gardner Jason
Vasconcelles Michael
Nichols David Wayne
Olson Lisa
Humphrey Jeffrey
Ronneberg Amy L
Scadden David
Albers Jeffrey W
Booth Bruce
Daniel Thomas O
Borisy Alexis
Bonney Michael W
Davis John C Jr
Zdraveski Zoran
Atlas Venture Fund X LP
Driscoll Cindy
Atlas Venture Opportunity Fund I LP
Atlas Venture Associates Opportunity I LLC
Atlas Venture Associates Opportunity I LP
Byers Blake
Ryan Jason
Isacson Christina K
Cooke Michael P
Atlas Venture Associates X LLC
Atlas Venture Associates X LP
Alphabet Inc
GV 2016 LP
GV 2016 GP LLC
GV 2016 GP LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Soteropoulos Paula
Stock Option (Right to Buy) · derivative
2026-03-24 Option exercise 27,594 $0.00
Soteropoulos Paula
Common Stock
2026-03-24 Sell 27,594 $78.05 2,153,712
Soteropoulos Paula
Common Stock
2026-03-24 Option exercise 27,594 $8.44 232,893
Garcia Marino
Common Stock
2026-03-16 Option exercise 5,592 $17.88 99,985
Garcia Marino
Stock Option (Right to Buy) · derivative
2026-03-16 Option exercise 59,700 $0.00
Garcia Marino
Common Stock
2026-03-16 Option exercise 59,700 $6.70 399,990
Garcia Marino
Stock Option (Right to Buy) · derivative
2026-03-16 Option exercise 5,592 $0.00
Carr Edward
Common Stock
2026-03-12 Option exercise 10,000 $21.77 217,700
Carr Edward
Common Stock
2026-03-12 Option exercise 17,500 $22.07 386,225
Carr Edward
Common Stock
2026-03-12 Option exercise 16,182 $17.88 289,334
Carr Edward
Common Stock
2026-03-12 Sell 15,852 $80.71 1,279,415
Carr Edward
Common Stock
2026-03-12 Sell 300 $85.53 25,659
Carr Edward
Common Stock
2026-03-12 Sell 200 $83.38 16,676
Carr Edward
Common Stock
2026-03-12 Sell 3,865 $82.66 319,481
Carr Edward
Common Stock
2026-03-12 Sell 23,465 $81.75 1,918,264
Randhawa Simrat
Common Stock
2026-03-12 Option exercise 12,500 $22.07 275,875
Randhawa Simrat
Common Stock
2026-03-12 Option exercise 8,332 $21.77 181,388
Randhawa Simrat
Common Stock
2026-03-12 Option exercise 5,000 $17.88 89,400
Randhawa Simrat
Common Stock
2026-03-12 Option exercise 7,998 $8.44 67,503
Randhawa Simrat
Common Stock
2026-03-12 Sell 33,830 $81.48 2,756,468
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 243 61,947,935
2025-12-31 166 48,430,246
2025-09-30 141 47,360,045
2025-06-30 105 39,240,863
2025-03-31 101 37,824,865
2024-12-31 97 35,112,883
2024-09-30 92 31,361,437
2024-06-30 75 29,697,947
2024-03-31 77 26,086,079
2023-12-31 40 10,604,836
2023-09-30 31 10,058,105
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 280,649 280,649
Moody Aldrich Partners LLC [2026-06-30] SOLE 35,058 74,552
Peak Financial Advisors LLC [2026-06-30] SOLE 0 19,689
Cary Street Partners Financial LLC [2026-06-30] DFND 3,596 3,645
PSP Research LLC [2026-06-30] SOLE 0 2,500
First Horizon Corp [2026-06-30] DFND 14 409
LRI Investments LLC [2026-06-30] SOLE 330 331
Gamma Investing LLC [2026-06-30] DFND 304 304
Grove Bank & Trust [2026-06-30] SOLE 0 61
Farther Finance Advisors LLC [2026-06-30] SOLE 0 36
Fortitude Family Office LLC [2026-06-30] SOLE 23 23
Handelsbanken Fonder AB [2026-06-30] SOLE 0 15
Eastern Bank [2026-06-30] DFND 10 10
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 4 4
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com